The effect of PD-L1 expression on breast cancer prognosis has only recently begun to be studied in clinical trials, and large breast cancer datasets, containing H&E and slides and corresponding PD-L1 expression annotations simply do not exist yet. This evidence concerns the gene CD274 and breast cancer.